Sagarkala Drugs And Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 50.00 K
- Company Age 1 Year 6 Months
About Sagarkala Drugs And Pharma
Sagarkala Drugs And Pharma Private Limited (SDAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 August 2023 (One year and six months 2 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sunil Roge and Anil Suryavanshi serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U46497MH2023PTC407995
-
Company No.
407995
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Aug 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Who are the key members and board of directors at Sagarkala Drugs And Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Roge
|
Director | 03-Aug-2023 | Current |
|
Anil Suryavanshi
|
Director | 03-Aug-2023 | Current |
Financial Performance of Sagarkala Drugs And Pharma.
Enhance accessibility to Sagarkala Drugs And Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sagarkala Drugs And Pharma?
Unlock access to Sagarkala Drugs And Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sagarkala Perfumery Private LimitedSunil Roge is a mutual person
-
Sagarkala Resins And Emulsions Private Limited
Sunil Roge is a mutual person
-
Sagarkala Infraeng Private Limited
Sunil Roge is a mutual person
-
P. P. S. Gagangiri Aqua Private Limited
Sunil Roge is a mutual person
-
Sagar Kala Constroeng Private Limited
Sunil Roge is a mutual person
-
P. P. Kalavati Devi Foods Private Limited
Sunil Roge is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sagarkala Drugs And Pharma?
Unlock and access historical data on people associated with Sagarkala Drugs And Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sagarkala Drugs And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sagarkala Drugs And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.